nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Tamoxifen—pancreatic cancer	0.0261	0.24	CbGbCtD
Conivaptan—CYP3A4—Erlotinib—pancreatic cancer	0.0222	0.204	CbGbCtD
Conivaptan—CYP3A4—Irinotecan—pancreatic cancer	0.02	0.185	CbGbCtD
Conivaptan—CYP3A4—Docetaxel—pancreatic cancer	0.0147	0.135	CbGbCtD
Conivaptan—CYP3A4—Sunitinib—pancreatic cancer	0.0146	0.135	CbGbCtD
Conivaptan—CYP3A4—Doxorubicin—pancreatic cancer	0.0109	0.101	CbGbCtD
Conivaptan—Atorvastatin—AHR—pancreatic cancer	0.0109	1	CrCbGaD
Conivaptan—Urinary tract disorder—Sunitinib—pancreatic cancer	0.00198	0.0045	CcSEcCtD
Conivaptan—Oedema peripheral—Sunitinib—pancreatic cancer	0.00197	0.00449	CcSEcCtD
Conivaptan—Sepsis—Docetaxel—pancreatic cancer	0.00197	0.00449	CcSEcCtD
Conivaptan—Urethral disorder—Sunitinib—pancreatic cancer	0.00196	0.00447	CcSEcCtD
Conivaptan—Phlebitis—Docetaxel—pancreatic cancer	0.00191	0.00436	CcSEcCtD
Conivaptan—Anaemia—Tamoxifen—pancreatic cancer	0.00188	0.00428	CcSEcCtD
Conivaptan—Cardiac disorder—Sunitinib—pancreatic cancer	0.00186	0.00423	CcSEcCtD
Conivaptan—Pneumonia—Irinotecan—pancreatic cancer	0.00185	0.00421	CcSEcCtD
Conivaptan—Angiopathy—Sunitinib—pancreatic cancer	0.00182	0.00414	CcSEcCtD
Conivaptan—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00181	0.00412	CcSEcCtD
Conivaptan—Mediastinal disorder—Sunitinib—pancreatic cancer	0.0018	0.00411	CcSEcCtD
Conivaptan—Pneumonia—Gemcitabine—pancreatic cancer	0.0018	0.0041	CcSEcCtD
Conivaptan—Pneumonia—Fluorouracil—pancreatic cancer	0.00177	0.00403	CcSEcCtD
Conivaptan—Infestation NOS—Fluorouracil—pancreatic cancer	0.00176	0.00401	CcSEcCtD
Conivaptan—Infestation—Fluorouracil—pancreatic cancer	0.00176	0.00401	CcSEcCtD
Conivaptan—Hypertension—Tamoxifen—pancreatic cancer	0.00176	0.004	CcSEcCtD
Conivaptan—Mental disorder—Sunitinib—pancreatic cancer	0.00175	0.00399	CcSEcCtD
Conivaptan—Malnutrition—Sunitinib—pancreatic cancer	0.00174	0.00397	CcSEcCtD
Conivaptan—Erythema—Sunitinib—pancreatic cancer	0.00174	0.00397	CcSEcCtD
Conivaptan—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00174	0.00396	CcSEcCtD
Conivaptan—Urinary tract infection—Fluorouracil—pancreatic cancer	0.00171	0.00389	CcSEcCtD
Conivaptan—Haematuria—Gemcitabine—pancreatic cancer	0.00171	0.00389	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.0017	0.00388	CcSEcCtD
Conivaptan—Dry mouth—Tamoxifen—pancreatic cancer	0.00169	0.00386	CcSEcCtD
Conivaptan—Cardiac failure—Docetaxel—pancreatic cancer	0.00169	0.00385	CcSEcCtD
Conivaptan—Hyponatraemia—Docetaxel—pancreatic cancer	0.00165	0.00377	CcSEcCtD
Conivaptan—Infection—Tamoxifen—pancreatic cancer	0.00165	0.00376	CcSEcCtD
Conivaptan—Infection—Erlotinib—pancreatic cancer	0.00163	0.00372	CcSEcCtD
Conivaptan—Nervous system disorder—Erlotinib—pancreatic cancer	0.00161	0.00367	CcSEcCtD
Conivaptan—Anaemia—Sunitinib—pancreatic cancer	0.00161	0.00367	CcSEcCtD
Conivaptan—Skin disorder—Erlotinib—pancreatic cancer	0.0016	0.00363	CcSEcCtD
Conivaptan—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00159	0.00361	CcSEcCtD
Conivaptan—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00158	0.0036	CcSEcCtD
Conivaptan—Urethral disorder—Gemcitabine—pancreatic cancer	0.00157	0.00359	CcSEcCtD
Conivaptan—Dehydration—Docetaxel—pancreatic cancer	0.00153	0.00349	CcSEcCtD
Conivaptan—Cardiac disorder—Irinotecan—pancreatic cancer	0.00153	0.00349	CcSEcCtD
Conivaptan—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.0015	0.00343	CcSEcCtD
Conivaptan—Hypertension—Sunitinib—pancreatic cancer	0.0015	0.00343	CcSEcCtD
Conivaptan—Insomnia—Tamoxifen—pancreatic cancer	0.0015	0.00342	CcSEcCtD
Conivaptan—Angiopathy—Irinotecan—pancreatic cancer	0.0015	0.00341	CcSEcCtD
Conivaptan—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00149	0.0034	CcSEcCtD
Conivaptan—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00149	0.00338	CcSEcCtD
Conivaptan—Insomnia—Erlotinib—pancreatic cancer	0.00149	0.00338	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00147	0.00336	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—pancreatic cancer	0.00146	0.00333	CcSEcCtD
Conivaptan—Angiopathy—Gemcitabine—pancreatic cancer	0.00146	0.00332	CcSEcCtD
Conivaptan—Dry mouth—Sunitinib—pancreatic cancer	0.00145	0.0033	CcSEcCtD
Conivaptan—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00145	0.0033	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00143	0.00327	CcSEcCtD
Conivaptan—Constipation—Tamoxifen—pancreatic cancer	0.00142	0.00323	CcSEcCtD
Conivaptan—Pain—Tamoxifen—pancreatic cancer	0.00142	0.00323	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00142	0.00323	CcSEcCtD
Conivaptan—Infection—Sunitinib—pancreatic cancer	0.00141	0.00322	CcSEcCtD
Conivaptan—Constipation—Erlotinib—pancreatic cancer	0.0014	0.0032	CcSEcCtD
Conivaptan—Pain—Erlotinib—pancreatic cancer	0.0014	0.0032	CcSEcCtD
Conivaptan—Erythema—Gemcitabine—pancreatic cancer	0.0014	0.00318	CcSEcCtD
Conivaptan—Nervous system disorder—Sunitinib—pancreatic cancer	0.00139	0.00318	CcSEcCtD
Conivaptan—Skin disorder—Sunitinib—pancreatic cancer	0.00138	0.00315	CcSEcCtD
Conivaptan—Erythema—Fluorouracil—pancreatic cancer	0.00137	0.00313	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—pancreatic cancer	0.00135	0.00308	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—pancreatic cancer	0.00133	0.00303	CcSEcCtD
Conivaptan—Anaemia—Irinotecan—pancreatic cancer	0.00133	0.00302	CcSEcCtD
Conivaptan—Body temperature increased—Erlotinib—pancreatic cancer	0.0013	0.00296	CcSEcCtD
Conivaptan—Anaemia—Gemcitabine—pancreatic cancer	0.00129	0.00294	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—pancreatic cancer	0.00129	0.00294	CcSEcCtD
Conivaptan—Insomnia—Sunitinib—pancreatic cancer	0.00129	0.00293	CcSEcCtD
Conivaptan—Pneumonia—Docetaxel—pancreatic cancer	0.00128	0.00291	CcSEcCtD
Conivaptan—Anaemia—Fluorouracil—pancreatic cancer	0.00127	0.00289	CcSEcCtD
Conivaptan—Infestation NOS—Docetaxel—pancreatic cancer	0.00127	0.00289	CcSEcCtD
Conivaptan—Infestation—Docetaxel—pancreatic cancer	0.00127	0.00289	CcSEcCtD
Conivaptan—Hypertension—Irinotecan—pancreatic cancer	0.00124	0.00282	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—pancreatic cancer	0.00123	0.0028	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00123	0.0028	CcSEcCtD
Conivaptan—Pain—Sunitinib—pancreatic cancer	0.00122	0.00277	CcSEcCtD
Conivaptan—Constipation—Sunitinib—pancreatic cancer	0.00122	0.00277	CcSEcCtD
Conivaptan—Hypertension—Gemcitabine—pancreatic cancer	0.00121	0.00275	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—pancreatic cancer	0.00119	0.00272	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00118	0.00269	CcSEcCtD
Conivaptan—Confusional state—Irinotecan—pancreatic cancer	0.00118	0.00269	CcSEcCtD
Conivaptan—Pruritus—Tamoxifen—pancreatic cancer	0.00117	0.00268	CcSEcCtD
Conivaptan—Infection—Irinotecan—pancreatic cancer	0.00116	0.00265	CcSEcCtD
Conivaptan—Pruritus—Erlotinib—pancreatic cancer	0.00116	0.00265	CcSEcCtD
Conivaptan—Nervous system disorder—Irinotecan—pancreatic cancer	0.00115	0.00262	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00114	0.00259	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—pancreatic cancer	0.00114	0.00259	CcSEcCtD
Conivaptan—Diarrhoea—Tamoxifen—pancreatic cancer	0.00114	0.00259	CcSEcCtD
Conivaptan—Infection—Gemcitabine—pancreatic cancer	0.00113	0.00258	CcSEcCtD
Conivaptan—Confusional state—Fluorouracil—pancreatic cancer	0.00113	0.00258	CcSEcCtD
Conivaptan—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00113	0.00256	CcSEcCtD
Conivaptan—Body temperature increased—Sunitinib—pancreatic cancer	0.00112	0.00256	CcSEcCtD
Conivaptan—Diarrhoea—Erlotinib—pancreatic cancer	0.00112	0.00256	CcSEcCtD
Conivaptan—Oedema peripheral—Docetaxel—pancreatic cancer	0.00112	0.00256	CcSEcCtD
Conivaptan—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00112	0.00255	CcSEcCtD
Conivaptan—Urethral disorder—Docetaxel—pancreatic cancer	0.00112	0.00254	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—pancreatic cancer	0.00112	0.00254	CcSEcCtD
Conivaptan—Infection—Fluorouracil—pancreatic cancer	0.00111	0.00254	CcSEcCtD
Conivaptan—Skin disorder—Gemcitabine—pancreatic cancer	0.00111	0.00252	CcSEcCtD
Conivaptan—Nervous system disorder—Fluorouracil—pancreatic cancer	0.0011	0.00251	CcSEcCtD
Conivaptan—Hypotension—Irinotecan—pancreatic cancer	0.00109	0.00249	CcSEcCtD
Conivaptan—Hypotension—Gemcitabine—pancreatic cancer	0.00107	0.00243	CcSEcCtD
Conivaptan—Insomnia—Irinotecan—pancreatic cancer	0.00106	0.00241	CcSEcCtD
Conivaptan—Cardiac disorder—Docetaxel—pancreatic cancer	0.00106	0.00241	CcSEcCtD
Conivaptan—Vomiting—Tamoxifen—pancreatic cancer	0.00106	0.0024	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—pancreatic cancer	0.00105	0.0024	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00105	0.0024	CcSEcCtD
Conivaptan—Hypotension—Fluorouracil—pancreatic cancer	0.00105	0.00239	CcSEcCtD
Conivaptan—Vomiting—Erlotinib—pancreatic cancer	0.00104	0.00238	CcSEcCtD
Conivaptan—Headache—Tamoxifen—pancreatic cancer	0.00104	0.00237	CcSEcCtD
Conivaptan—Angiopathy—Docetaxel—pancreatic cancer	0.00103	0.00236	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—pancreatic cancer	0.00103	0.00235	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—pancreatic cancer	0.00103	0.00235	CcSEcCtD
Conivaptan—Insomnia—Gemcitabine—pancreatic cancer	0.00103	0.00235	CcSEcCtD
Conivaptan—Headache—Erlotinib—pancreatic cancer	0.00103	0.00234	CcSEcCtD
Conivaptan—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00103	0.00234	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00101	0.00231	CcSEcCtD
Conivaptan—Insomnia—Fluorouracil—pancreatic cancer	0.00101	0.00231	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—pancreatic cancer	0.00101	0.0023	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00101	0.0023	CcSEcCtD
Conivaptan—Pruritus—Sunitinib—pancreatic cancer	0.00101	0.00229	CcSEcCtD
Conivaptan—Pain—Irinotecan—pancreatic cancer	0.001	0.00228	CcSEcCtD
Conivaptan—Constipation—Irinotecan—pancreatic cancer	0.001	0.00228	CcSEcCtD
Conivaptan—Mental disorder—Docetaxel—pancreatic cancer	0.000998	0.00227	CcSEcCtD
Conivaptan—Erythema—Docetaxel—pancreatic cancer	0.000992	0.00226	CcSEcCtD
Conivaptan—Malnutrition—Docetaxel—pancreatic cancer	0.000992	0.00226	CcSEcCtD
Conivaptan—Nausea—Tamoxifen—pancreatic cancer	0.000986	0.00225	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000985	0.00224	CcSEcCtD
Conivaptan—Pain—Gemcitabine—pancreatic cancer	0.000976	0.00222	CcSEcCtD
Conivaptan—Constipation—Gemcitabine—pancreatic cancer	0.000976	0.00222	CcSEcCtD
Conivaptan—Nausea—Erlotinib—pancreatic cancer	0.000976	0.00222	CcSEcCtD
Conivaptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000973	0.00222	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000969	0.00221	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.000965	0.0022	CcSEcCtD
Conivaptan—Pain—Fluorouracil—pancreatic cancer	0.000959	0.00219	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—pancreatic cancer	0.000956	0.00218	CcSEcCtD
Conivaptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00094	0.00214	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000939	0.00214	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000936	0.00213	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000926	0.00211	CcSEcCtD
Conivaptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000924	0.00211	CcSEcCtD
Conivaptan—Anaemia—Docetaxel—pancreatic cancer	0.000917	0.00209	CcSEcCtD
Conivaptan—Vomiting—Sunitinib—pancreatic cancer	0.000904	0.00206	CcSEcCtD
Conivaptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000902	0.00205	CcSEcCtD
Conivaptan—Headache—Sunitinib—pancreatic cancer	0.000891	0.00203	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—pancreatic cancer	0.000887	0.00202	CcSEcCtD
Conivaptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000887	0.00202	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000866	0.00197	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—pancreatic cancer	0.000861	0.00196	CcSEcCtD
Conivaptan—Hypertension—Docetaxel—pancreatic cancer	0.000857	0.00195	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—pancreatic cancer	0.000856	0.00195	CcSEcCtD
Conivaptan—Infestation—Epirubicin—pancreatic cancer	0.000856	0.00195	CcSEcCtD
Conivaptan—Nausea—Sunitinib—pancreatic cancer	0.000845	0.00192	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—AGTR1—pancreatic cancer	0.000839	0.0019	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000839	0.00191	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000833	0.00189	CbGpPWpGaD
Conivaptan—Urinary tract infection—Epirubicin—pancreatic cancer	0.000832	0.0019	CcSEcCtD
Conivaptan—Dry mouth—Docetaxel—pancreatic cancer	0.000826	0.00188	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—pancreatic cancer	0.000821	0.00187	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—pancreatic cancer	0.000816	0.00186	CcSEcCtD
Conivaptan—Confusional state—Docetaxel—pancreatic cancer	0.000816	0.00186	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—GAST—pancreatic cancer	0.000814	0.00184	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GAST—pancreatic cancer	0.000808	0.00183	CbGpPWpGaD
Conivaptan—Pruritus—Gemcitabine—pancreatic cancer	0.000807	0.00184	CcSEcCtD
Conivaptan—Infection—Docetaxel—pancreatic cancer	0.000804	0.00183	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000802	0.00183	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000801	0.00183	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—pancreatic cancer	0.000797	0.00182	CcSEcCtD
Conivaptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000794	0.00181	CcSEcCtD
Conivaptan—Pruritus—Fluorouracil—pancreatic cancer	0.000794	0.00181	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—pancreatic cancer	0.000792	0.0018	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—pancreatic cancer	0.000792	0.0018	CcSEcCtD
Conivaptan—Skin disorder—Docetaxel—pancreatic cancer	0.000786	0.00179	CcSEcCtD
Conivaptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.000781	0.00178	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—SCT—pancreatic cancer	0.000771	0.00175	CbGpPWpGaD
Conivaptan—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00077	0.00175	CcSEcCtD
Conivaptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000768	0.00175	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—SCT—pancreatic cancer	0.000766	0.00173	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000759	0.00173	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—pancreatic cancer	0.000757	0.00173	CcSEcCtD
Conivaptan—Hypotension—Docetaxel—pancreatic cancer	0.000757	0.00172	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—pancreatic cancer	0.000755	0.00172	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—pancreatic cancer	0.000754	0.00172	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.000753	0.0017	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.000747	0.00169	CbGpPWpGaD
Conivaptan—Vomiting—Irinotecan—pancreatic cancer	0.000745	0.0017	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—GAST—pancreatic cancer	0.000739	0.00167	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCK—pancreatic cancer	0.000736	0.00167	CbGpPWpGaD
Conivaptan—Headache—Irinotecan—pancreatic cancer	0.000734	0.00167	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—GAST—pancreatic cancer	0.000734	0.00166	CbGpPWpGaD
Conivaptan—Insomnia—Docetaxel—pancreatic cancer	0.000732	0.00167	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CCK—pancreatic cancer	0.00073	0.00165	CbGpPWpGaD
Conivaptan—Vomiting—Gemcitabine—pancreatic cancer	0.000725	0.00165	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CNR2—pancreatic cancer	0.000717	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000717	0.00162	CbGpPWpGaD
Conivaptan—Headache—Gemcitabine—pancreatic cancer	0.000715	0.00163	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—pancreatic cancer	0.000713	0.00163	CcSEcCtD
Conivaptan—Vomiting—Fluorouracil—pancreatic cancer	0.000713	0.00162	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000712	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000712	0.00161	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000705	0.0016	CbGpPWpGaD
Conivaptan—Headache—Fluorouracil—pancreatic cancer	0.000703	0.0016	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000702	0.0016	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000701	0.0016	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—SCT—pancreatic cancer	0.0007	0.00159	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.0007	0.00159	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000699	0.00159	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—pancreatic cancer	0.000697	0.00159	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—pancreatic cancer	0.000697	0.00159	CcSEcCtD
Conivaptan—Nausea—Irinotecan—pancreatic cancer	0.000696	0.00158	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—SCT—pancreatic cancer	0.000695	0.00157	CbGpPWpGaD
Conivaptan—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000693	0.00158	CcSEcCtD
Conivaptan—Pain—Docetaxel—pancreatic cancer	0.000692	0.00158	CcSEcCtD
Conivaptan—Constipation—Docetaxel—pancreatic cancer	0.000692	0.00158	CcSEcCtD
Conivaptan—Nausea—Gemcitabine—pancreatic cancer	0.000678	0.00154	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—pancreatic cancer	0.000673	0.00153	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PRLHR—pancreatic cancer	0.00067	0.00152	CbGpPWpGaD
Conivaptan—Erythema—Epirubicin—pancreatic cancer	0.000669	0.00152	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—pancreatic cancer	0.000669	0.00152	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCK—pancreatic cancer	0.000668	0.00151	CbGpPWpGaD
Conivaptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.000667	0.00152	CcSEcCtD
Conivaptan—Nausea—Fluorouracil—pancreatic cancer	0.000666	0.00152	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—PRLHR—pancreatic cancer	0.000665	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCK—pancreatic cancer	0.000663	0.0015	CbGpPWpGaD
Conivaptan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00066	0.0015	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CNR2—pancreatic cancer	0.000651	0.00147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GLP1R—pancreatic cancer	0.000651	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR2—pancreatic cancer	0.000646	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000646	0.00146	CbGpPWpGaD
Conivaptan—Angiopathy—Doxorubicin—pancreatic cancer	0.000645	0.00147	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000641	0.00146	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—CCKAR—pancreatic cancer	0.000641	0.00145	CbGpPWpGaD
Conivaptan—Body temperature increased—Docetaxel—pancreatic cancer	0.00064	0.00146	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000636	0.00144	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IAPP—pancreatic cancer	0.000635	0.00144	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000631	0.00143	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.00063	0.00143	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.00063	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000625	0.00142	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000625	0.00142	CbGpPWpGaD
Conivaptan—Mental disorder—Doxorubicin—pancreatic cancer	0.000623	0.00142	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—pancreatic cancer	0.000619	0.00141	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—pancreatic cancer	0.000619	0.00141	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—pancreatic cancer	0.000618	0.00141	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00061	0.00138	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000605	0.00137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—SHH—pancreatic cancer	0.000584	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SHH—pancreatic cancer	0.00058	0.00131	CbGpPWpGaD
Conivaptan—Hypertension—Epirubicin—pancreatic cancer	0.000578	0.00132	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—IAPP—pancreatic cancer	0.000577	0.00131	CbGpPWpGaD
Conivaptan—Pruritus—Docetaxel—pancreatic cancer	0.000573	0.0013	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—IAPP—pancreatic cancer	0.000573	0.0013	CbGpPWpGaD
Conivaptan—Anaemia—Doxorubicin—pancreatic cancer	0.000572	0.0013	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SSTR3—pancreatic cancer	0.000569	0.00129	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DTX1—pancreatic cancer	0.000569	0.00129	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000566	0.00129	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—DTX1—pancreatic cancer	0.000565	0.00128	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SSTR3—pancreatic cancer	0.000565	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—SST—pancreatic cancer	0.000558	0.00126	CbGpPWpGaD
Conivaptan—Dry mouth—Epirubicin—pancreatic cancer	0.000557	0.00127	CcSEcCtD
Conivaptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000554	0.00126	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—PTHLH—pancreatic cancer	0.000554	0.00125	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PTCH1—pancreatic cancer	0.000554	0.00125	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—SST—pancreatic cancer	0.000554	0.00125	CbGpPWpGaD
Conivaptan—Confusional state—Epirubicin—pancreatic cancer	0.000551	0.00125	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—PTCH1—pancreatic cancer	0.00055	0.00124	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTHLH—pancreatic cancer	0.00055	0.00124	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000547	0.00124	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000546	0.00124	CbGpPWpGaD
Conivaptan—Infection—Epirubicin—pancreatic cancer	0.000543	0.00124	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—SSTR1—pancreatic cancer	0.000542	0.00123	CbGpPWpGaD
Conivaptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.000536	0.00122	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PPY—pancreatic cancer	0.000535	0.00121	CbGpPWpGaD
Conivaptan—Hypertension—Doxorubicin—pancreatic cancer	0.000535	0.00122	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—PPY—pancreatic cancer	0.000532	0.0012	CbGpPWpGaD
Conivaptan—Skin disorder—Epirubicin—pancreatic cancer	0.00053	0.00121	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000526	0.00119	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000524	0.00119	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—SSTR2—pancreatic cancer	0.000522	0.00118	CbGpPWpGaD
Conivaptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000516	0.00117	CcSEcCtD
Conivaptan—Vomiting—Docetaxel—pancreatic cancer	0.000515	0.00117	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CNR1—pancreatic cancer	0.000515	0.00117	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000511	0.00116	CbGpPWpGaD
Conivaptan—Hypotension—Epirubicin—pancreatic cancer	0.00051	0.00116	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—pancreatic cancer	0.00051	0.00116	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000508	0.00115	CbGpPWpGaD
Conivaptan—Headache—Docetaxel—pancreatic cancer	0.000507	0.00116	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—SST—pancreatic cancer	0.000506	0.00115	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000505	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCKBR—pancreatic cancer	0.000504	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SST—pancreatic cancer	0.000503	0.00114	CbGpPWpGaD
Conivaptan—Infection—Doxorubicin—pancreatic cancer	0.000502	0.00114	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000501	0.00113	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000498	0.00113	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GCG—pancreatic cancer	0.000497	0.00113	CbGpPWpGaD
Conivaptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000496	0.00113	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—pancreatic cancer	0.000494	0.00113	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—GCG—pancreatic cancer	0.000493	0.00112	CbGpPWpGaD
Conivaptan—Skin disorder—Doxorubicin—pancreatic cancer	0.000491	0.00112	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000484	0.00109	CbGpPWpGaD
Conivaptan—Nausea—Docetaxel—pancreatic cancer	0.000481	0.0011	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—GLI1—pancreatic cancer	0.000477	0.00108	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DTX4—pancreatic cancer	0.000477	0.00108	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000474	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DTX4—pancreatic cancer	0.000474	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GLI1—pancreatic cancer	0.000474	0.00107	CbGpPWpGaD
Conivaptan—Hypotension—Doxorubicin—pancreatic cancer	0.000472	0.00108	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000471	0.00107	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000471	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000471	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000467	0.00106	CbGpPWpGaD
Conivaptan—Pain—Epirubicin—pancreatic cancer	0.000467	0.00106	CcSEcCtD
Conivaptan—Constipation—Epirubicin—pancreatic cancer	0.000467	0.00106	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000464	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000464	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000464	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRP1—pancreatic cancer	0.000461	0.00104	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000461	0.00104	CbGpPWpGaD
Conivaptan—Insomnia—Doxorubicin—pancreatic cancer	0.000457	0.00104	CcSEcCtD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000455	0.00103	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GCG—pancreatic cancer	0.000451	0.00102	CbGpPWpGaD
Conivaptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.00045	0.00103	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—GCG—pancreatic cancer	0.000448	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HEY2—pancreatic cancer	0.000447	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HEY2—pancreatic cancer	0.000444	0.001	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAST—pancreatic cancer	0.000436	0.000988	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000436	0.000994	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—GAST—pancreatic cancer	0.000433	0.000981	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000432	0.000979	CbGpPWpGaD
Conivaptan—Pain—Doxorubicin—pancreatic cancer	0.000432	0.000984	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—pancreatic cancer	0.000432	0.000984	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000432	0.000983	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000431	0.000975	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000427	0.000968	CbGpPWpGaD
Conivaptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000416	0.000949	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SCT—pancreatic cancer	0.000414	0.000937	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000414	0.000937	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SCT—pancreatic cancer	0.000411	0.00093	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HEY1—pancreatic cancer	0.000411	0.00093	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.0004	0.000906	CbGpPWpGaD
Conivaptan—Body temperature increased—Doxorubicin—pancreatic cancer	0.000399	0.00091	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCK—pancreatic cancer	0.000395	0.000894	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCK—pancreatic cancer	0.000392	0.000887	CbGpPWpGaD
Conivaptan—Pruritus—Epirubicin—pancreatic cancer	0.000386	0.00088	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000385	0.000871	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000385	0.000871	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000384	0.000871	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR2—pancreatic cancer	0.000382	0.000865	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GLP1R—pancreatic cancer	0.000382	0.000865	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000382	0.000864	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000378	0.000857	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCKAR—pancreatic cancer	0.000376	0.000851	CbGpPWpGaD
Conivaptan—Diarrhoea—Epirubicin—pancreatic cancer	0.000374	0.000851	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000367	0.000831	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAG2—pancreatic cancer	0.000364	0.000825	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000362	0.000819	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MEN1—pancreatic cancer	0.000359	0.000813	CbGpPWpGaD
Conivaptan—Pruritus—Doxorubicin—pancreatic cancer	0.000358	0.000814	CcSEcCtD
Conivaptan—Vomiting—Epirubicin—pancreatic cancer	0.000347	0.000791	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—pancreatic cancer	0.000346	0.000788	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SHH—pancreatic cancer	0.000345	0.000781	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000343	0.000776	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SHH—pancreatic cancer	0.000343	0.000776	CbGpPWpGaD
Conivaptan—Headache—Epirubicin—pancreatic cancer	0.000342	0.000779	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—IAPP—pancreatic cancer	0.000341	0.000772	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00034	0.000771	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IAPP—pancreatic cancer	0.000338	0.000766	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000327	0.000741	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000327	0.000741	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000325	0.000735	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000325	0.000735	CbGpPWpGaD
Conivaptan—Nausea—Epirubicin—pancreatic cancer	0.000324	0.000739	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—pancreatic cancer	0.000321	0.000732	CcSEcCtD
Conivaptan—Headache—Doxorubicin—pancreatic cancer	0.000317	0.000721	CcSEcCtD
Conivaptan—Nausea—Doxorubicin—pancreatic cancer	0.0003	0.000684	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—SST—pancreatic cancer	0.000299	0.000677	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SST—pancreatic cancer	0.000297	0.000673	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000295	0.000668	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000293	0.000663	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000293	0.000663	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000292	0.00066	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JAG1—pancreatic cancer	0.000291	0.000658	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000289	0.000655	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000276	0.000625	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR1—pancreatic cancer	0.000274	0.000621	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000268	0.000607	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GCG—pancreatic cancer	0.000267	0.000604	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000266	0.000602	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GCG—pancreatic cancer	0.000265	0.000599	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000259	0.000587	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000257	0.000583	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000254	0.000576	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000253	0.000572	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STK11—pancreatic cancer	0.000251	0.000568	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STK11—pancreatic cancer	0.000249	0.000564	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000236	0.000533	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000234	0.00053	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000226	0.000512	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000224	0.000508	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMAD4—pancreatic cancer	0.00022	0.000497	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000218	0.000494	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000217	0.000492	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000216	0.000488	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HES1—pancreatic cancer	0.000214	0.000485	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HES1—pancreatic cancer	0.000213	0.000482	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000205	0.000465	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000204	0.000462	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000197	0.000447	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000196	0.000444	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TERT—pancreatic cancer	0.000188	0.000425	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TERT—pancreatic cancer	0.000186	0.000422	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HIF1A—pancreatic cancer	0.00018	0.000407	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TSC2—pancreatic cancer	0.000179	0.000406	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HIF1A—pancreatic cancer	0.000178	0.000404	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TSC2—pancreatic cancer	0.000178	0.000403	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—pancreatic cancer	0.000175	0.000397	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—pancreatic cancer	0.000174	0.000394	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KDR—pancreatic cancer	0.000172	0.000389	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KDR—pancreatic cancer	0.000171	0.000386	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000163	0.00037	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000162	0.000367	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000162	0.000366	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000161	0.000364	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000158	0.000358	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NRAS—pancreatic cancer	0.000158	0.000358	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000157	0.000356	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NRAS—pancreatic cancer	0.000157	0.000356	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGF—pancreatic cancer	0.000156	0.000354	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGF—pancreatic cancer	0.000155	0.000352	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—pancreatic cancer	0.000144	0.000327	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—pancreatic cancer	0.000143	0.000324	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000139	0.000315	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000138	0.000313	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000138	0.000312	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000137	0.00031	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—pancreatic cancer	0.000136	0.000308	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—pancreatic cancer	0.000135	0.000306	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000125	0.000283	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000124	0.000281	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000121	0.000275	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CB—pancreatic cancer	0.00012	0.000273	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—pancreatic cancer	0.000117	0.000264	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—pancreatic cancer	0.000116	0.000262	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—pancreatic cancer	0.000116	0.000262	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—pancreatic cancer	0.000115	0.00026	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000113	0.000255	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000112	0.000253	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CASP3—pancreatic cancer	0.000112	0.000253	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CASP3—pancreatic cancer	0.000111	0.000251	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—pancreatic cancer	0.000109	0.000246	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—pancreatic cancer	0.000108	0.000244	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000108	0.000243	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000107	0.000242	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—pancreatic cancer	0.000105	0.000239	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—pancreatic cancer	0.000105	0.000237	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—pancreatic cancer	0.000105	0.000237	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—pancreatic cancer	0.000104	0.000236	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—pancreatic cancer	0.000102	0.000232	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—pancreatic cancer	0.000101	0.00023	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SRC—pancreatic cancer	9.72e-05	0.00022	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SRC—pancreatic cancer	9.65e-05	0.000218	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—pancreatic cancer	9.47e-05	0.000214	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—pancreatic cancer	9.4e-05	0.000213	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—pancreatic cancer	9.37e-05	0.000212	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NRAS—pancreatic cancer	9.35e-05	0.000212	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—pancreatic cancer	9.3e-05	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRAS—pancreatic cancer	9.28e-05	0.00021	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	8.77e-05	0.000199	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—pancreatic cancer	8.71e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—pancreatic cancer	8.69e-05	0.000197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—pancreatic cancer	8.65e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—pancreatic cancer	8.63e-05	0.000195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—pancreatic cancer	8.52e-05	0.000193	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—pancreatic cancer	8.46e-05	0.000192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—pancreatic cancer	8.05e-05	0.000182	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—pancreatic cancer	7.99e-05	0.000181	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.61e-05	0.000172	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—pancreatic cancer	7.39e-05	0.000167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—pancreatic cancer	7.34e-05	0.000166	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—pancreatic cancer	7.15e-05	0.000162	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—pancreatic cancer	7.1e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—pancreatic cancer	6.84e-05	0.000155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—pancreatic cancer	6.79e-05	0.000154	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.65e-05	0.000151	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—pancreatic cancer	6.04e-05	0.000137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—pancreatic cancer	6e-05	0.000136	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.36e-05	0.000121	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.27e-05	0.000119	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5e-05	0.000113	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD44—pancreatic cancer	3.88e-05	8.78e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCG—pancreatic cancer	3.72e-05	8.41e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STK11—pancreatic cancer	3.49e-05	7.91e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMS—pancreatic cancer	3e-05	6.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—pancreatic cancer	2.44e-05	5.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.21e-05	4.99e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.13e-05	4.82e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.94e-05	4.39e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.69e-05	3.83e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.67e-05	3.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.46e-05	3.31e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.03e-05	2.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.42e-06	1.91e-05	CbGpPWpGaD
